Cargando…

Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact

Death receptor 5 (DR5) and caspase-8 are major components in the extrinsic apoptotic pathway. The alterations of the expression of these proteins during the metastasis of head and neck squamous cell carcinoma (HNSCC) and their prognostic impact have not been reported. The present study analyzes the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elrod, Heath A., Fan, Songqing, Muller, Susan, Chen, Georgia Z., Pan, Lin, Tighiouart, Mourad, Shin, Dong M., Khuri, Fadlo R., Sun, Shi-Yong
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922336/ https://www.ncbi.nlm.nih.gov/pubmed/20808443 http://dx.doi.org/10.1371/journal.pone.0012178

Ejemplares similares

caGrid-Enabled caBIG(TM) Silver Level Compatible Head and Neck Cancer Tissue Database System
por: Wang, Haibin, et al.
Publicado: (2010)

Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis
por: Uzunparmak, Burak, et al.
Publicado: (2020)

Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling
por: Oh, You-Take, et al.
Publicado: (2015)

Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma
por: Zhang, H, et al.
Publicado: (2008)

Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
por: Li, Rui, et al.
Publicado: (2013)

Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer
por: Maleš, Josip, et al.
Publicado: (2021)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Making the head: Caspases in life and death
por: Svandova, Eva, et al.
Publicado: (2023)

Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wakasaki, Takahiro, et al.
Publicado: (2020)

On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy
por: Nenclares, Pablo, et al.
Publicado: (2021)

c-Jun NH(2)-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL
por: Fu, Lei, et al.
Publicado: (2010)

In Lebanon “It Never Rains But It Pours”—How the American University of Beirut faced dangers and seized opportunities: Transforming medical education through multiple crises
por: Khuri, Fadlo R.
Publicado: (2021)

Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10
por: Raulf, N, et al.
Publicado: (2014)

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
por: van der Linden, Naomi, et al.
Publicado: (2015)

Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
por: Chen, Wen-Chun, et al.
Publicado: (2017)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016)

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
por: Magnes, Teresa, et al.
Publicado: (2021)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

c-FLIP Degradation Mediates Sensitization of Pancreatic Cancer Cells to TRAIL-Induced Apoptosis by the Histone Deacetylase Inhibitor LBH589
por: Kauh, John, et al.
Publicado: (2010)

Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Sakai, Akihiro, et al.
Publicado: (2023)

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
por: Müller, Tim, et al.
Publicado: (2017)

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
por: Pivot, X, et al.
Publicado: (2001)

Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma
por: Mokhtari, Sepideh
Publicado: (2012)

Role of EGF inhibitors in the treatment of recurrent or metastatic squamous cell head and neck cancer
por: Lorch, Jochen H
Publicado: (2009)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
por: Sukari, Ammar, et al.
Publicado: (2015)

Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck
por: Guenne, Clémence, et al.
Publicado: (2014)

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Argiris, Athanassios, et al.
Publicado: (2017)

Socioeconomic factors and survival in patients with non‐metastatic head and neck squamous cell carcinoma
por: Xu, Cheng, et al.
Publicado: (2017)

Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma
por: Arron, Sarah T., et al.
Publicado: (2022)

ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study
por: Zielinski, Valerie, et al.
Publicado: (2012)

Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas
por: Knauer, Shirley K.
Publicado: (2009)

Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
por: Dequanter, D, et al.
Publicado: (2015)

Prognostic factors of cervical node status in head and neck squamous cell carcinoma
por: Burusapat, Chairat, et al.
Publicado: (2015)

LTBP2 is a prognostic marker in head and neck squamous cell carcinoma
por: Han, Liang, et al.
Publicado: (2016)

The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma
por: Grsic, Kresimir, et al.
Publicado: (2016)

Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck
por: Boucek, Jan, et al.
Publicado: (2010)

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
por: Cho, Yoon Ah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lsjlun9ksofip5kmho9tm1g3uv